RESUMEN
No disponible
No disponible
Asunto(s)
Masculino , Adulto , Humanos , Amiodarona/efectos adversos , Parálisis Periódica Hipopotasémica/inducido químicamente , Tirotoxicosis , Fibrilación Atrial/tratamiento farmacológicoRESUMEN
No disponible
Asunto(s)
Masculino , Femenino , Anciano , Humanos , Hemorragia Cerebral/inducido químicamente , Ginkgo biloba/efectos adversos , Aspirina/uso terapéuticoAsunto(s)
Bacteriemia/diagnóstico , Citrobacter , Infecciones por Enterobacteriaceae/diagnóstico , Neumonía Bacteriana/diagnóstico , Anciano , Anciano de 80 o más Años , Bacteriemia/microbiología , Citrobacter/aislamiento & purificación , Infecciones Comunitarias Adquiridas/diagnóstico , Infecciones Comunitarias Adquiridas/microbiología , Infecciones por Enterobacteriaceae/microbiología , Femenino , Humanos , Neumonía Bacteriana/microbiologíaRESUMEN
No disponible
Asunto(s)
Anciano de 80 o más Años , Anciano , Femenino , Humanos , Citrobacter , Bacteriemia , Neumonía Bacteriana , Infecciones Comunitarias Adquiridas , Infecciones por EnterobacteriaceaeRESUMEN
OBJECTIVES: Describing the bacteriological map of the urinary tract infections (UTI) in our area including intra and extrahospitalized patients during 1997. MATERIAL AND METHODS: Descriptive-retrospective study, 12,937 urocultives were carried out in our laboratory: 847 from hospitalized patients and 12,090 from 15 Health Centres. RESULTS: 1,527 positive cultures (12.6%) were obteined from Health Centre patients and 215 (25.3%) from hospitalized patients. Bacterial distribution was similar between them, except enterocci and negative coagulase estafilococci which were more frequent in hospitalized patients. We have observed a high prevalence of Enterobacter sp. (4%) and Pseudomonas sp. (4%) which disagrees with other studies. E.coli (presents in 69% of the positive urocultives) was widespread resistant to quinolones, pipemidic acid and nitrofuration, while it had high sensitivity to fosfomicin, cephuroxim and amoxicilin-clavulanic acid. CONCLUSIONS: The level of resistance to the quinolones is considerable in our area, so clinicians should give them up in empirical treatment and use fosfomicine, cephuroxime or amoxicilin-clavulanic acid.